Daily Stock List
Q Lotus Holdings, Inc. (QLTS)
HotShotStocks, Buzz Stocks, Bull Warrior Stocks, Stock Brain, Stockhunter.us, MajorPennyStocks, Premium Trade Alerts, World Wide Market News, USA Market News, and Savvy Stock Picks reported previously on Q Lotus Holdings, Inc. (QLTS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Q Lotus Holdings, Inc. formed to operate as a financial services company for their operating subsidiaries. As of September 30, 2012, the Company had two wholly owned subsidiaries. One is Q Lotus, Inc. (QLI), a Nevada Corporation whose operations have consisted of the acquisition of certain mining claims. The other is Midwest Business Credit, Inc. (MBC), a Nevada corporation formed to acquire the assets of Midwest Business Credit, LLC (MBC, LLC); an asset based lending company, which provides secured financing. Q Lotus Holdings lists on the OTCBB; the Company is based in Chicago, Illinois.
Q Lotus Holdings is a diversified financial services holding company. They provide financing and they acquire growing companies, whereby they believe their management participation in operations can create additional value. The Company's principal investment focus is to provide equity and debt capital to growing and middle-market companies with increasing cash flow and escalating income in the areas of Finance, Real Estate and Mining.
Q Lotus Holdings is a development stage company. They are in their initial stage of operations. The Company has funded their operations so far from proceeds received from the sale of their common stock totaling approximately $805,000, from advances made by the Company's Chairman, and other advances from unaffiliated third parties. Currently, the Company's business has consisted exclusively of holding mineral rights in a portfolio of minerals. Their activities have been limited to the formation of the legal and business structure, business planning, the pursuit of capital and the exploration of possible acquisitions and investments.
At the end of January 2012, Midwest Business Credit, Inc. (MBC, Inc), a wholly owned subsidiary of Q Lotus Holdings, concluded a definitive agreement for the purchase of the assets and the business of Midwest Business Credit, LLC (MBC, LLC), consistent with the previous announcement made by Q Lotus on December 14, 2011.
Q Lotus Holdings' intention is to expand their holdings by either acquiring additional subsidiaries to facilitate their business plan, or acquiring either minority or controlling interests in companies that they identify as undervalued and/or where their management participation in operations can aid in the recognition of the business's potential fair value and create additional value, to make capital investments in an array of privately held companies, or invest in real estate assets.
They anticipate that the primary revenue sources will come from revenues from acquired operations, and interest, dividends, rents, royalties and capital gains (from loans and equity investments) in both startup companies with proprietary technology and medium sized businesses with an established operating history.
Q Lotus Holdings, Inc. (QLTS), closed Friday's trading session at $0.1075, up 53.57%, on 672,947 volume with 52 trades. The average volume for the last 60 days is 48,891 and the stock's 52-week low/high is $0.01/$0.33.
Empowered Products, Inc. (EMPO)
SmallCapInvestorDaily, OTCtipReporter, PennyStockScholar, Contrarian Press, and Super Stock Investor reported earlier on Empowered Products, Inc. (EMPO), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Listed on the OTC Market's OTCQB, Empowered Products, Inc. has a leading presence in the international wellness industry. The Company has developed, manufactured, and now distributes 17 high quality wellness products. Their products are available at over 3,000 retail locations in more than 30 countries spanning four continents. Empowered Products is based in Las Vegas, Nevada.
Through their select marketing and sponsorship endeavors, Empowered Products is steadily establishing strong brand awareness for their PINK® and Gun-Oil® lines of sexual lubricants and libido enhancing supplements. They market their products through a network of distributors, wholesalers, pharmacies, and chain and online retailers in North America, Europe, and Asia; as well as sells directly to retail consumers through their online store.
In 2012, the Company had a significant number of direct consumers sign-on to their online sites and product storefronts. These include www.EmpoweredProducts.com, www.PinkforUs.com, and www.GunOil.com. Empowered Products objective is to garner 1 million direct consumer sign-ups by the mid-point of 2013.
Empowered Products offers a line of topical gels, lotions, and oils. These are formulated to increase mental focus and improve the bond of interpersonal relationships. Empowered Products provides products for men under the aforementioned Gun-Oil ® trademark and products for women under the aforementioned PINK® trademark.
In October 2012, Empowered Products announced that they received their first purchase order from TARGET.com, a division of the Target Corporation, dated October 8, 2012. The initial order included both PINK and Gun-Oil silicone and water-based personal lubricants as well as the hybrid lubricants, PINK Indulgence and Gun-Oil Loaded.
This week, Empowered Products announced the Company's first order filled in Japan. Through their subsidiary based in Hong Kong, they fulfilled the initial order from Love Piece Club of Tokyo. This order included PINK Silicone, PINK Water and Hot PINK personal lubricants and PINK Frolic for toys.
Mr. Scott Fraser, President and Chief Executive Officer of Empowered Products, commented, "Our new entry into the vast Japanese consumer markets represents another important milestone in our expanding global sales network of over the 30 countries and a significant new source of revenues."
Empowered Products, Inc. (EMPO), closed Friday's trading session at $0.32, even for the day, on 1,525 volume with 4 trades. The average volume for the last 60 days is 15,875 and the stock's 52-week low/high is $0.12/$1.32.
Estrella Gold Corp. (EST.V)
Streetwise Reports reported previously on Estrella Gold Corp. (EST.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Estrella Gold Corp. is a "Prospect Generator" focusing on gold exploration in Latin America. The Company identifies and acquires new mineral properties, and subsequently conducts initial, low-cost exploration to define a potential new deposit. Once defined, Estrella forms Joint Ventures (JVs) with other companies that will provide funding and reduce Estrella's risk and expenditures.
Incorporated in 1996, the Company was formerly known as Canadian Shield Resources Ltd. They changed their name to Estrella Gold Corp. in August of 2010. Estrella Gold has their headquarters in Vancouver, British Columbia. The Company's shares trade on the TSX Venture Exchange.
The Prospect Generator business model allows the Company to look aggressively for the next major discovery. Estrella Gold has 23 active exploration properties in Peru - 14 held in venture agreements, most in a strategic exploration alliance with Cliffs Natural Resources Exploration, Inc., a wholly owned subsidiary of Cliffs Natural Resources, Inc.
Of the nine properties held 100 percent by Estrella Gold, they have six new epithermal gold targets, two early stage epithermal gold targets, and the Colpayoc gold-porphyry target that has an NI 43-101 compliant inferred gold resource containing 313,000 ounces of oxide gold (19.3 Mt @ 0.5 g/t gold, Global Geotechnologies, Inc.; News Release dated December 21, 2011).
In early December 2012, Estrella Gold announced that Cliffs Natural Resources Exploration accepted the Yanac Property as a JV Project. Cliffs and Estrella each now hold a 50 percent interest in the property, and Cliffs must spend a firm commitment of US$500,000 in year one on exploration or payment to Estrella; with an additional US$250,000 (not firm) to a total of US$750,000 to maintain their interest beyond year one.
This week, Estrella Gold announced that Mr. John R. Wilson was appointed President and Chief Executive Officer. Mr. Wilson has more than 40 years of experience and success in all aspects of base and precious metals exploration, discovery, reserve definition, and mine development. His work has included discoveries in Brazil, Nevada, and Peru. Additionally, he has performed detailed evaluations of several deposits and prospect types in diverse geological settings throughout the western United States, Russia, Chile, Peru, Brazil, Mexico, Central America, and Asia.
Estrella Gold Corp. (EST.V), closed Friday's trading session at $0.10, down 9.09%, on 5,000 volume. The stock's 52-week low/high is $0.09/$0.45.
Laredo Resources Corp. (LRDR)
Today we are reporting on Laredo Resources Corp. (LRDR), here at the QualityStocks Daily Newsletter.
Laredo Resources Corp. is an exploration stage company that focuses on the exploration of mineral properties in the United States. The Company does this by way of their wholly owned subsidiary, LRE Exploration, LLC, a Nevada limited liability company. Laredo Resources explores for gold, silver, lead, zinc, copper, tungsten, as well as barite deposits.
The Company's shares trade on the OTC Bulletin Board. Incorporated in 2010, Laredo Resources has their corporate headquarters in Vancouver, British Columbia. The Company owns an option to acquire an undivided 100 percent beneficial interest in the ABR Claims located in Elko County in the State of Nevada. They hold an option to the mineral exploration rights relating to the mineral claims in the ABR Claims. The ABR claims consist of 20 adjoining unpatented mineral claims totaling 413 acres. Each claim is approximately 1,500 feet by 600 feet.
Laredo Resources' strategy with the ABR mineral claims and other prospects deemed to be of higher risk or those that would require very large exploration expenditures is to present them to larger companies for Joint Venture (JV). If Laredo presents a property to a major company and they are not interested, they will continue to look for an interested partner.
This week, Mr. Robert Gardner, President of Laredo Resources, announced that 38 additional mining claims on the Pony Mountain property near Pony, Montana, were located and physically staked by Mr. Gene Nellis (Geologist) and his staking crew, under contract with Magna Management Ltd., the optionor for the Pony Mountain property.
These claims are now filed in the Virginia City Courthouse in Montana. Upon completion of the documentation, filings will take place with the Bureau of Land Management (BLM), which will complete the process. Because of these new stakings, the total package under option amounts to 110 unpatented mining claims in the Mineral Hill District at Pony, Montana.
Laredo Resources' option to acquire the property has been extended to February 20, 2013 by agreement with the owners. Meanwhile, Magna continues to make the ongoing monthly payments set out in their contract. This extension continues to secure Laredo Resources' position and opportunity in terms of becoming the owner of the Pony Mountain property.
Laredo Resources Corp. (LRDR), closed Friday's trading session at $0.35, up 12.90%, on 32,982 volume with 7 trades. The average volume for the last 60 days is 10,144 and the stock's 52-week low/high is $0.003/$0.56.
Tree Top Industries, Inc. (TTIID)
Today we are reporting on Tree Top Industries, Inc. (TTIID), here at the QualityStocks Daily Newsletter.
Tree Top Industries, Inc. is a mini conglomerate, based on Teledyne's original business model. The Company's subsidiaries and affiliates include intellectual properties, proprietary systems, and trade secrets in the bioscience, nanoscience, clean-tech, and global health technologies, among other new and emerging technologies. Tree Top is in the development stage.
The Company is actively acquiring companies and technologies utilizing many different business paradigms. These include exchange of stock, Joint Venture, and other partnership configurations. Tree Top Industries' shares trade on the OTC Bulletin Board. The Company has their corporate headquarters in New York, New York.
The Company's subsidiaries and affiliates include NetThruster, Inc., BioEnergy Applied Tech., Eye Care Centers Int., GoHealth. MD Nano Pharmaceuticals and Sky Entertainment. Net Thruster offers Live event streaming, on-demand video, as well as video formats.
The BioEnergy Applied Tech. (BAT) solution allows waste liability to be eliminated from a company's balance sheet, regulatory affairs, and risk management systems. Using innovative technology and the waste chemicals' own stored energy via their covalent bonds; BAT can inexpensively and completely break down these chemicals into more environmentally friendly molecules. The BAT Solution is on-site; it eliminates the transport and disposal of waste.
Eye Care centers formed to support the further growth and development of WolrdWithoutBlindness (WWB). This organization's primary mission is to bring patented eye screening equipment to the developing world. GoHealth.MD Nano Pharmaceuticals formed in early 2012 to house the patents, intellectual properties and professional expertise of the doctors involved in Adesso Biosciences, Ltd., when Tree Top Industries acquires that company. Sky Entertainment formed to house the potential acquisition of Sky Corp. Sky is based in Belgrade, Serbia and is the largest event production and management company in South Eastern Europe.
In August 2012, Tree Top Industries confirmed that they received a $10,000,000 Reserve Equity Financing Facility from AGS Capital Group, LLC in order to enable growth in their previously announced two-fold business plan. AGS Capital Group is a United States based specialist investor group.
Tree Top Industries, Inc. (TTIID), closed Friday's trading session at $1.20, up 9.09%, on 300 volume with 3 trades. The average volume for the last 60 days is 5,964 and the stock's 52-week low/high is $0.27/$5.00.
Terralene Fuels Corp. (GSPT)
Investor News Source reported last week on Terralene Fuels Corp. (GSPT), Wallstreetlivechat did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Terralene Fuels Corp. provides alternative renewable fuels. Founded in 1993, the Company formerly went by the name Golden Spirit Enterprises Ltd. They changed their corporate name to Terralene Fuels Corp. on November 29, 2011. Terralene Fuels has their headquarters in Patchogue, New York.
In 2010, the Company signed an agreement with Global Terralene, Inc. for the acquisition of all assets pertaining to TERRALENE® Fuels. TERRALENE® Fuel is a patented fuel alternative formulation that is the equivalent of 87 octane regular gasoline. It utilizes renewable energy sources in 45 percent of its composition. Terralene's unique fuel reduces greenhouse gas and other environmental damaging emissions and can undergo easy integration into the existing fuel infrastructure.
The basis of TERRALENE® is somewhat upon fossil fuels and non food chain agricultural components. The design of it is as a replacement clean & green Alternative Renewable Fuel that can satisfy currently existing engine designs, while simultaneously addressing environmental concerns. The design of the TERRALENE® Family of Fuels is also to enhance the economic well being of the consumer while reducing the dependence on fossil fuel feed stocks. Furthermore, TERRALENE® fuels are also able to meet the Alternative Renewable Fuel Specifications, which are becoming standardized globally.
No major hardware modifications or additions are required for most engine systems. In addition, TERRALENE® fuels are compatible with smaller 4-stroke gasoline engines and diesels and in hybrid vehicles.
The Company signed an agreement with EnEco Industries to participate in a series of Municipal Solid Waste (MSW) (garbage) fueled Recycling and Resource Recovery Plants. The Agreement calls for a Joint Venture using EnEco's expertise and technology to develop a MSW recycling and biomass derived renewable energy facility. With this agreement, they together will build and operate a series of solid waste recycling and biomass derived renewable energy facilities with greenhouse and algae subsystems that will utilize their Thermal Oxidation Process System (TOPS) technology to generate electricity for sale to the local power grid.
Terralene Fuels Corp. (GSPT), closed Friday's trading session at $0.0032, up 68.42%, on 3,525,335 volume with 42 trades. The average volume for the last 60 days is 721,241 and the stock's 52-week low/high is $0.0005/$0.009.
CanAlaska Uranium Ltd. (CVVUF)
FeedBlitz reported previously on CanAlaska Uranium Ltd. (CVVUF), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, CanAlaska Uranium Ltd. is undertaking exploration across 4,000 sq. miles of territory in Canada's prolific Athabasca Basin. The Company is engaging in uranium exploration in twenty one uranium projects in the Athabasca Basin. Their key uranium properties are the West McArthur Project, the Cree East Project, NW Manitoba, and Fond du Lac. CanAlaska Uranium has their corporate headquarters in Vancouver, British Columbia.
CanAlaska acts as a professional exploration operator for their strategic partners. They provide expertise, geophysical and geological personnel, in addition to project management services in operations, contracting, logistics, community relations and environment, health and safety.
CanAlaska Uranium, since September of 2004, has acquired one of the largest land positions in the region, consisting of up to 2,100,000 acres (8720 sq. km or 3,906 sq. miles). The Company has delineated multiple uranium targets.
The Company has built long-term relationships with global strategic partners to provide exploration funding. Japan's Mitsubishi Corp. has funded Cdn$12.5 million towards exploration on the West McArthur Project as a 50 percent Joint Venture partner. Likewise, a Korean consortium led by Hanwha, and consisting of KEPCO, KORES, and SK Networks, has invested Cdn$19.0 million in the Cree East Project, earning a 50 percent ownership interest.
CanAlaska Uranium is now actively marketing their uranium exploration projects in the Athabasca basin area. They have entered into agreements to allow third party technical review. Presently, the Company has 878,813 ha of property under exploration titles, and expects to maintain the core properties of this land position through December 31, 2013 (min. 582,776 ha). There are certain land positions, where there has been recent active exploration, where title is current through 2032.
Yesterday, CanAlaska Uranium announced their acquisition of three claim groups, totaling 6,687 ha, located in the Patterson Lake area of the western Athabasca basin. The claims were competitively staked on the first day of Saskatchewan's new map-based claim staking in December 2012. CanAlaska is reviewing plans for exploration and is now looking for a Joint Venture (JV) partner to participate with exploration in this area, where there have been recent uranium discoveries at shallow depths.
Moreover, the Company has also finalized maintenance budgets on the Joint Ventured Cree East and West McArthur projects. CanAlaska Uranium is actively marketing a participating interest in these projects via KPMG Transaction Advisory Services in Hong Kong.
CanAlaska Uranium Ltd. (CVVUF), closed Friday's trading session at $0.291, up 12.36%, on 29,600 volume with 7 trades. The average volume for the last 60 days is 4,183 and the stock's 52-week low/high is $0.145/$0.57.
International Isotopes, Inc. (INIS)
SmallCapVoice reported previously on International Isotopes, Inc. (INIS), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
International Isotopes, Inc. manufactures a full spectrum of nuclear medicine calibration and reference standards, high purity fluoride gases, and an assortment of cobalt-60 products such as teletherapy sources. They also provide a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications. In addition, the Company provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients. International Isotopes is headquartered in Idaho Falls, Idaho. The Company lists on the OTC Bulletin Board.
International Isotopes' core business consists of six reportable segments. These include Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services, and Transportation. The Company has their planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility located near Hobbs, New Mexico. They believe this new commercial facility will provide an excellent commercial opportunity. International Isotopes holds patents that give them exclusive rights for the Fluorine Extraction Process (FEP). This process produces high value, high purity fluoride gasses in tandem with uranium de-conversion.
The Company has developed a unique process to convert depleted uranium tails (the by-product produced from the enrichment of uranium) to ultra high purity, high value industrial fluoride products. Fluoride products are a key raw material for microelectronics, fiber optic cable, thin film photovoltaics (solar cells) and numerous other manufacturing processes.
In November 2011, International Isotopes announced that they completed an agreement in principle with Idaho State University to develop, jointly, processes for the production of Copper-67. Copper-67 has shown exceptional potential in the treatment of non-Hodgkin's Lymphoma and bladder, colorectal, and ovarian cancers. However, it is a difficult isotope to produce and has not been consistently made available in the U.S.
In October 2012, International Isotopes announced that they received a license from the U.S. Nuclear Regulatory Commission (NRC) to build a depleted uranium de-conversion and fluorine extraction processing facility. The license, which has a 40-year term, was signed October 2, 2012 by the NRC. The NRC had been reviewing International Isotopes' plan since 2009.
The plant will use a two-step process to extract fluorine from depleted uranium. This is for use in solar materials, microelectronics and the petrochemical markets.
International Isotopes, Inc. (INIS), closed Friday's trading session at $0.16, up 6.67%, on 22,000 volume with 2 trades. The average volume for the last 60 days is 65,617 and the stock's 52-week low/high is $0.061/$0.32.
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.07, up 9.38%, on 5,473,653 volume with 239 trades. The stock’s average daily volume over the past 60 days is 3,053,154, and its 52-week low/high is $0.0275/$0.178.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis to Present at the 6th Annual OneMedForum
Advaxis Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development Officer
Advaxis Receives Preliminary Approval for Sale of Losses from State of NJ Economic Development Authority
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.235, up 2.17%, on 191,438 volume with 26 trades. The stock’s average daily volume over the past 60 days is 142,246, and its 52-week low/high is $0.161/$0.65.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Positive Animal Efficacy Results in Liver Disease Program
International Stem Cell Corporation to Participate in Biotech Showcase 2013 on January 7th
Lifeline Skin Care a Subsidiary of ISCO Announces New Sales and Multi-Media Marketing Campaigns
The Guitammer Company Inc. (GTMM)
The QualityStocks Daily Newsletter would like to spotlight The Guitammer Company Inc. (GTMM). Today, The Guitammer Company Inc. closed trading at $0.16, even for the day, on 100 volume with 1 trade. The stock’s average daily volume over the past 60 days is 13,364, and its 52-week low/high is $0.082/$0.35.
The Guitammer Company Inc. (GTMM) is a leader in low-frequency sound products and technology. The company’s award-winning line of patented ButtKicker brand audio transducers let users actually feel the excitement, impacts, special effects, and bone-rattling bass brought by its immersive “4D” patent-protected technology. Guitammer’s products are well known for being musically accurate, powerful, and virtually indestructible.
The Guitammer Company was founded in 1990 by Ken McCaw, an accomplished musician, composer, and producer. Joining forces with Marvin Clamme, former sound engineer for Tom Jones and Merle Haggard, Ken and Marvin developed the original ButtKicker transducer prototypes in 1994.
Today, the ButtKicker brand products are used around the world by leading entertainment and theater companies, including AMC, IMAX, and Disney, in movie theaters and attractions. 85 entertainment locations in 11 countries have incorporated ButtKicker products to-date, providing the ultimate experience to over 10,000 seats. The products are also used in home theaters, simulators, and car audio applications.
Guitammer’s technology is compatible to virtually any digital source, including cable, satellite, fiber optic, IPTV, “over-the-air” broadcast, video games, and audio CDs. The ButtKicker brand products add unparalleled realism and excitement to movies, music, and games. Guitammer’s low-frequency, high-impact sound innovation is the next logical step after HDTV, 3DTV, and TiVo, bringing ground-breaking changes in how consumers enjoy their entertainment. Disclaimer
The Guitammer Company Inc. Company Blog
The Guitammer Company Inc. News:
Guitammer Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
Guitammer Third Quarter Revenue More Than Triples To $555,000
Guitammer CEO Mark Luden to Present at 7th Annual Singular Research 'Best of the Uncovereds' Conference in Los Angeles
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.73, even for the day. The stock’s average daily volume over the past 60 days is 1,438 and its 52-week low/high is $0.06/$3.10.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
VistaGen's lead drug candidate, AV-101, is in Phase Ib development in the U.S. for treatment of neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Therapeutics Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium
VistaGen Therapeutics Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System -- LiverSafe 3Dô
VistaGen Therapeutics and Duke University Announce Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions
Timberline Resources, the domestic gold developer focused on advanced-stage targets in the western U.S., including properties like their flagship Lookout Mountain project on the company’s 23 square-mile South Eureka land package in Nevada (one of the biggest remaining undeveloped sites in the state and on-trend with Barrick Gold’s 2M oz Archimedes/Ruby Hill mine), reported appointing 40-year mining industry veteran, Leigh W. Freeman, to the company’s Board today. Freeman is also set to receive 100k common stock options at an exercise price equal to fair market value at the time of the grant (immediate vesting, five-year term).
This appointment brings Mr. Freeman into a key managerial and oversight role where his vast first-hand industry experience and professional connections will serve TLR shareholders well as the company advances its growing portfolio of assets. Assets that include a 50% carried interest ownership stake in the Butte Highlands Joint Venture over in Montana, which is slated to commence production sometime here in the middle of this year and which saw some choice returns like a 33.6-foot interval grading 1.65 opt Au (with a 5-foot interval grading 10.45 opt) in the company’s recent 53k-foot underground diamond drilling program.
With this kind of massive exposure to developable resources, it is no wonder TLR moved to grab a guy like Freeman, who currently serves as GM and Principal over at eminent and internationally recognized recruitment consultancy firm, Downing Teal, which has a built up a tremendous reputation for solving the difficult challenges of finding the right, qualified personnel for sector interests that range from mining, to construction, and energy production. Freeman is also CEO and Director over at noted private producer/marketer of premium renewable fuel products, like top-shelf B100 biodiesel, Blue Sun Energy.
President and CEO of TLR, Paul Dircksen, hailed the appointment as a major coup for the company ahead of the run up to production at Butte and his presence will also seriously help to speed along developments at the sprawling South Eureka project (latest NI 43-101 on the Lookout Mountain site shows 221k oz Au inferred). Dircksen also applauded the efforts of out-going Director Ron Guill, who has been on the Board since 2007 and has helped spearhead much of the work at Butte, confirming to shareholders that Ron will continue to support the company’s portfolio development roadmap.
Freeman really knows the game and has paid his dues in the industry’s trenches, serving in a variety of executive, managerial, and technical roles at both junior and senior mining/service companies. For instance, Freeman co-founded Orvana Minerals and also served as President/Director, handling multiple, similar positions at Placer Dome as well. Mr. Freeman is very well connected in the industry as a whole, serving as a trustee on the industry advisory board for the University of Arizona’s mining programs and in the same capacity for the Montana Tech Foundation. Freeman even co-chaired the Society of Mining Engineer’s Education Sustainability Committee and was appointed to the National Academy of Science’s “Emerging Workforce Trends in the US Energy and Mining Industries” ad hoc committee as the mining representative.
The precious metals space is really heating up across the board and that is great news for domestic developers like TLR. With gold, platinum, silver, and other precious metals all attracting more and more investment capital amid consistently turbulent long-term global economic forecasts, we see a bullish trend in metals typified by things like yesterday’s report out of Reuters that the U.S. Mint just ran out of American Eagle silver bullion coins due to skyrocketing demand from investors and has ceased sales until Jan 28.
For more information on Timberline Resources, visit www.Timberline-Resources.com
OCZ Technology Group, a prominent supplier of high-performance solid-state drives (SSDs) for computing devices and systems, announced that it has signed an agreement with Intcomex regarding the rights to distribute OCZ’s entire line of consumer-based SSDs in Latin America and the Caribbean. A recent addition to the OCZ portfolio is the new Vector SSD Series. This new product group is based on the advanced Barefoot 3 controller that features the industry’s fastest I/O performance and enterprise-like endurance which has earned the Vector SSD Series dozens of Editors Choice Awards worldwide. On top of the flagship Vector Series, Intcomex will be carrying the PCIe-based RevoDrive Series and OCZ’s popular SATA-based Vertex Series and Agility Series.
Intcomex is the largest pure-play value-added distributor of IT products dedicated to serving the Latin American and Caribbean markets, and it is completely focused on distributing computer equipment components, networking products, peripherals, software, etc. to over 40 countries represented in those markets, in addition to giving customers a one-stop shop by stocking more than 13,000 products from greater than 140 vendors. With twelve ‘in-country’ distribution offices in Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Jamaica, Mexico, Panama, Peru, and Uruguay, Intcomex is the optimum company to deliver the product mix, services, support, and training to its local networks of resellers, large-scale retailers, and system integrators significantly quicker and in a more personal manner.
“We are very excited to complement our existing IT portfolio with leading solid-state drives from OCZ which are highly regarded in our region for their technical innovation, leading performance, advanced drive life and extreme affordability,” said Carlos Ruzal, Director of Purchasing and Product Management for Intcomex. “As part of our support for OCZ’s SSD portfolio, we deliver a unique set of services including training on new products, technical support, warranty services, assistance with customs, duties and taxes, and efficient shipping and receiving processes that has become the driving force behind our stellar customer service and continued success.”
“We are pleased to expand our distribution strategy in Latin America and the Caribbean with Intcomex who is completely dedicated and focused on providing the complementary IT products and value-added services that high-tech resellers are accustomed to,” said E. Zeke Olazaba, Director of Sales-Latin America for OCZ Technology. “As a key distribution partner in the region, with a rich line-card of IT products and unique services, we anticipate that that this partnership will extend into enterprise applications supporting other areas of the data center.”
With yesterday’s announcement, OCZ is in a position to greatly increase its market penetration in a growing region with a leading distribution partner and network of resellers supporting all customers including small to large businesses, home and entertainment users, and communities covering banking, financial, government, and corporate.
For further information, please visit www.intcomex.com
Indianapolis-based Noble Roman’s sells and services franchises and licenses for non-traditional food service operations under the trade names “Noble Roman’s Pizza,” “Noble Roman’s Take-n-Bake,” and “Tuscano’s Italian Style Subs.” The company has awarded franchise and/or license agreements in 49 states along with Puerto Rico, the Bahamas, Canada, and Italy.
The company announced today further expansion of its popular take-n-bake concept. A third Noble Roman’s stand-alone take-n-bake franchise unit opened in the Indianapolis metro area. It was dubbed “Noble Roman’s Take-n-Bake P’za”.
Noble Roman’s take-n-bake concept features the food chain’s traditional hand-tossed style pizza, deep-dish Sicilian pizza, the SuperThin pizza, and its famous breadsticks with spicy cheese sauce. Other menu items include fresh salad, cookie dough, cinnamon rounds, bake-able pasta, cheesy sticks, and more. All the tasty food is offered in a convenient cook-at-home format.
The company has signed additional new franchise agreements, bringing the total number of TNB units open or in development to nine. Six units are currently under development or construction and are expected to open during the first half of 2013. It has also licensed over 1,350 grocery stores nationwide to carry Noble Roman’s take-n-bake pizza.
For further information about Noble Roman, please visit www.nobleromans.com
After going from highs of 75 cents to lows around 35 cents, BFDI is holding its ground in the middle now. A wedge has formed with the stock moving upwards towards the topside of the trendline, putting it on watch for continued upward pressure towards static resistance at 58 cents.
To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) to Present at the 6th Annual OneMedForum
- Bergamo Acquisition Corp. (BGMO) Signs Investment Agreement
- Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report With the Securities and Exchange Commission
- Cardium Therapeutics, Inc. (CXM) To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives
- The Guitammer Company Inc. (GTMM) Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Announces Positive Animal Efficacy Results in Liver Disease Program
- Loans4Less.com, Inc. (LFLS) Provides Preliminary Financial Results for Year Ended December, 31 2012
- TNI BioTech Inc. (TNIB) Acquires the Exclusive Rights to Low Dose Naltrexone and Other Opioid Antagonists for the Treatment of Inflammatory and Ulcerative Diseases of the Bowel
- Viaspace, Inc. (VSPC) Giant King Grass Energy Crop Growing in Hawaii
- Viscount Systems, Inc. (VSYS) Systems Awarded New U.S. Government Contract
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium